Johnson & Johnson To Seek FDA Approval For COVID-19 Booster Shot: Report
Johnson & Johnson (NYSE: JNJ) is reportedly planning to ask U.S. federal regulators to authorize a booster shot of its COVID-19 vaccine.
Benzinga’s Bulls And Bears Of The Week: Apple, Boeing, Moderna, Robinhood And More
Benzinga has examined the prospects for many investor favorite stocks over the past week.
Last week's bullish calls included FAANG stock picks and aerospace and automotive giants.
Is Moderna About To Bounce?
Moderna Inc. (NASDAQ: MRNA) shares are trading lower Friday as most COVID-19 related stocks dropped.
35 Stocks Moving In Friday’s Mid-Day Session
Gainers
Biomerica, Inc. (NASDAQ: BMRA) shares climbed 38.3% to $6.23. Biomerica entered into a Supplier Agreement with Walmart to sell its EZ Detect colorectal disease screening test within the Walmart retail system.
Why Moderna, Novavax And Other COVID-19 Vaccine Stocks Are Plummeting
The COVID-19 pandemic proved to be a boon for many biopharma companies that benefited from their foray into the development of vaccines and/or treatments against the novel coronavirus. Shares of most of them reached incredibly high valuations even after discounting for the COVID opportunity.